WSJ details Putin’s $26B push to achieve organ replacement by 2030

Putin’s $26 Billion Longevity Program Targets Organ Replacement by 2030

When Vladimir Putin was caught on a hot microphone telling Xi Jinping last September that humans could achieve immortality by replacing their organs, some dismissed the exchange as eccentric chatter between aging leaders. But according to a report published by the Wall Street Journal on May 29, Putin was describing a real and sprawling Kremlin-backed initiative that has become one of Russia’s flagship scientific projects.x

A State Priority Built on Radical Science

The program, called “New Health Preservation Technologies,” was unveiled in 2024 and carries a price tag of $26 billion. It encompasses bioprinting of living tissue, xenotransplantation using genetically modified mini-pigs, cryotherapy involving ultralow temperatures, and gene therapy aimed at slowing cellular aging. Russian scientists connected to the initiative claim to have already bioprinted human cartilage tissue and a mouse thyroid gland, with the stated goal of achieving full human organ replacement by 2030.indiatimes

Deputy Prime Minister Tatyana Golikova officially presented the project in May 2024, and the government has said it aims to save 175,000 lives by the end of the decade. In April, Deputy Science Minister Denis Sekirinsky announced that researchers were developing a gene-therapy drug targeting the RAGE receptor, calling it “one of the most promising avenues in the fight against aging”.kyivpost

Family Ties and Kremlin Insiders

The initiative is led by Putin’s eldest daughter, endocrinologist Maria Vorontsova, and physicist Mikhail Kovalchuk, head of the Kurchatov Institute. Vorontsova, who was sanctioned by the United States and European Union in 2022, has been described by the U.S. Treasury Department as directing “state-funded programs that have received billions of dollars from the Kremlin for genetic research” personally overseen by Putin. She is considered the informal supervisor of a separate 127 billion-ruble genetics program run through the Kurchatov Institute.united24media

Skepticism and Context

The Wall Street Journal compared Putin’s pursuit to that of Silicon Valley figures including Jeff Bezos, Sam Altman, and Peter Thiel, who have invested heavily in anti-aging research. But experts have expressed doubt about Russia’s capacity to deliver results. Medical professionals have questioned whether the country can accomplish such goals without adequate funding pipelines and amid a brain drain of scientific talent. Human trials for the gene-therapy drug have not yet begun, and researchers caution that claims of reversing aging remain speculative.nmn

The program nonetheless reflects the Kremlin’s willingness to channel vast state resources toward what Kovalchuk believes science will eventually achieve: the ability to repair and replace human body parts entirely.ndtv